首页> EJNMMI radiopharmacy and chemistry> SPECT/CT imaging of EGFR-positive head and neck squamous cell carcinoma patient-derived xenografts with <sup>203</sup>Pb-PSC-panitumumab in NRG mice.

SPECT/CT imaging of EGFR-positive head and neck squamous cell carcinoma patient-derived xenografts with <sup>203</sup>Pb-PSC-panitumumab in NRG mice.

导出 LinkOut

翻译打印收藏纠错

第一作者： Nasim,Sarrami

第一单位： Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Canada.

作者： Nasim,Sarrami ^[1] ; Bryce,Nelson ^[2] ; Samantha,Leier ^[2] ; John,Wilson ^[2] ; Conrad,Chan ^[3] ; Jalna,Meens ^[4] ; Teesha,Komal ^[5] ; Laurie,Ailles ^[6] ; Melinda,Wuest ^[2] ; Michael,Schultz ^[7] ; Afsaneh,Lavasanifar ^[1] ; Raymond M,Reilly ^[8] ; Frank,Wuest ^[9]

作者单位： Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Canada. ^[1] Department of Oncology, Cross Cancer Institute, University of Alberta, 11560- University Avenue, Edmonton, AB, T6G 1Z2, Canada. ^[2] Leslie Dan Faculty of Pharmacy and Department of Pharmaceutical Sciences, University of Toronto, Toronto, Canada. ^[3] Princess Margaret Cancer Centre, Toronto, Canada. ^[4] STTARR Innovation Centre, University Health Network, Toronto, Canada. ^[5] Princess Margaret Cancer Centre, Toronto, Canada.;Department of Medical Biophysics, University of Toronto, Toronto, Canada. ^[6] Viewpoint Molecular Targeting, Inc, Coralville, IA, USA. ^[7] Leslie Dan Faculty of Pharmacy and Department of Pharmaceutical Sciences, University of Toronto, Toronto, Canada.;Princess Margaret Cancer Centre, Toronto, Canada. ^[8] Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Canada. wuest@ualberta.ca.;Department of Oncology, Cross Cancer Institute, University of Alberta, 11560- University Avenue, Edmonton, AB, T6G 1Z2, Canada. wuest@ualberta.ca.;Department of Chemistry, University of Alberta, Edmonton, Canada. wuest@ualberta.ca.;Cancer Research Institute of Northern Alberta, University of Alberta, Edmonton, Canada. wuest@ualberta.ca. ^[9]

关键词 Epidermal growth factor receptor (EGFR)Panitumumab Pb-203 Pb-212 Radiotheranostics Single-Photon Emission Computed Tomography (SPECT)

DOI 10.1186/s41181-024-00313-8

PMID 39589608

发布时间 2024-11-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

EJNMMI radiopharmacy and chemistry

2024年9卷1期

79页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

EJNMMI radiopharmacy and chemistry

2024年9卷1期

79页

检索历史清除

SPECT/CT imaging of EGFR-positive head and neck squamous cell carcinoma patient-derived xenografts with <sup>203</sup>Pb-PSC-panitumumab in NRG mice.

EJNMMI radiopharmacy and chemistry

相似文献

同项目论文

EJNMMI radiopharmacy and chemistry

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

SPECT/CT imaging of EGFR-positive head and neck squamous cell carcinoma patient-derived xenografts with <sup>203</sup>Pb-PSC-panitumumab in NRG mice.

EJNMMI radiopharmacy and chemistry

相似文献

同项目论文

EJNMMI radiopharmacy and chemistry

相关期刊

检索历史清除